Neonatal Abstinence Syndrome

"Neonatal Abstinence Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Fetal and neonatal addiction and withdrawal as a result of the mother's dependence on drugs during pregnancy. Withdrawal or abstinence symptoms develop shortly after birth. Symptoms exhibited are loud, high-pitched crying, sweating, yawning and gastrointestinal disturbances.

Descriptor ID	D009357
MeSH Number(s)	C16.614.610 C25.775.650 F03.900.650
Concept/Terms	Neonatal Abstinence Syndrome Neonatal Abstinence Syndrome Substance Withdrawal, Neonatal Neonatal Withdrawal Syndrome Neonatal Withdrawal Syndromes Syndrome, Neonatal Withdrawal Syndromes, Neonatal Withdrawal Withdrawal Syndrome, Neonatal Withdrawal Syndromes, Neonatal Abstinence Syndrome, Neonatal Abstinence Syndromes, Neonatal Neonatal Abstinence Syndromes Syndrome, Neonatal Abstinence Syndromes, Neonatal Abstinence Neonatal Substance Withdrawal Neonatal Substance Withdrawals Substance Withdrawals, Neonatal Withdrawal, Neonatal Substance Passive Addiction, Neonatal Passive Addiction, Neonatal Addiction, Neonatal Passive Addictions, Neonatal Passive Neonatal Passive Addiction Neonatal Passive Addictions Passive Addictions, Neonatal

Below are MeSH descriptors whose meaning is more general than "Neonatal Abstinence Syndrome".

Diseases [C]
Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
Infant, Newborn, Diseases [C16.614]
Neonatal Abstinence Syndrome [C16.614.610]
Chemically-Induced Disorders [C25]
Substance-Related Disorders [C25.775]
Neonatal Abstinence Syndrome [C25.775.650]
Psychiatry and Psychology [F]
Mental Disorders [F03]
Substance-Related Disorders [F03.900]
Neonatal Abstinence Syndrome [F03.900.650]

Below are MeSH descriptors whose meaning is related to "Neonatal Abstinence Syndrome".

Below are MeSH descriptors whose meaning is more specific than "Neonatal Abstinence Syndrome".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Neonatal Abstinence Syndrome" by people in this website by year, and whether "Neonatal Abstinence Syndrome" was a major or minor topic of these publications.

Bar chart showing 36 publications over 18 distinct years, with a maximum of 5 publications in 2020 and 2024

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2003	1	0	1
2004	1	0	1
2005	1	0	1
2007	2	0	2
2008	3	1	4
2010	3	0	3
2011	0	1	1
2012	0	1	1
2015	1	0	1
2016	1	0	1
2017	2	0	2
2019	4	0	4
2020	4	1	5
2021	1	0	1
2022	1	0	1
2023	1	0	1
2024	4	1	5
2025	1	0	1

Below are the most recent publications written about "Neonatal Abstinence Syndrome" by people in Profiles.

Durrance CP, Pac J, Berger LM, Reilly A, Ehrenthal D. Prenatal opioid exposure, neonatal abstinence syndrome diagnosis, and child welfare involvement. Child Abuse Negl. 2025 03; 161:107246.

View in: PubMed
Wang Y, Ehrenthal DB, Zhang L. Distinct Trajectories of Prescription Opioid Exposure in Pregnancy and Risk of Adverse Birth Outcomes. J Addict Med. 2025 Jan-Feb 01; 19(1):53-61.

View in: PubMed
Anderson VA, Anbalagan S, Favara MT, Stark D, Carola D, Solarin KO, Adeniyi-Jones S, Aghai ZH. Sex-Related Differences in the Severity of Neonatal Opioid Withdrawal Syndrome: A Single-Center, Retrospective Cohort Study. Am J Perinatol. 2025 02; 42(3):363-368.

View in: PubMed
Anbalagan S, Anderson V, Favara MT, Stark D, Carola D, Solarin K, Adeniyi-Jones S, Kraft WK, Aghai ZH. Buprenorphine vs. morphine: impact on neonatal opioid withdrawal syndrome (NOWS) outcomes in a single center retrospective study. J Perinatol. 2025 Apr; 45(4):473-479.

View in: PubMed
Berger LM, Durrance C, Ehrenthal D, Kim H, Kuo HH, Pac J. Prenatal opioid exposure by likelihood of exposure and risk to prenatal development: Medicaid-covered births in Wisconsin, 2010-2019. Sci Adv. 2024 05 10; 10(19):eadg9674.

View in: PubMed
Mallinson DC, Kuo HD, Kirby RS, Wang Y, Berger LM, Ehrenthal DB. Maternal opioid use disorder and infant mortality in Wisconsin, United States, 2010-2018. Prev Med. 2024 04; 181:107914.

View in: PubMed
Wang Y, Berger L, Durrance C, Kirby RS, Kuo D, Pac J, Ehrenthal DB. Duration and Timing of In Utero Opioid Exposure and Incidence of Neonatal Withdrawal Syndrome. Obstet Gynecol. 2023 09 01; 142(3):603-611.

View in: PubMed
Friedman D, Zubair N, Favara MT, Lafferty M, Carola D, Adeniyi-Jones S, Solarin K, Aghai ZH. Do small for gestational age infants have less severe neonatal abstinence syndrome? J Neonatal Perinatal Med. 2022; 15(4):753-758.

View in: PubMed
Favara MT, Smith J, Friedman D, Lafferty M, Carola D, Adeniyi-Jones S, Greenspan J, Aghai ZH. Growth failure in infants with neonatal abstinence syndrome in the neonatal intensive care unit. J Perinatol. 2022 Mar; 42(3):313-318.

View in: PubMed
Smith J, Lafferty M, Boelig RC, Carola D, Adeniyi-Jones S, Kraft WK, Greenspan JS, Aghai ZH. Is Maternal Methadone Dose Associated with the Severity of Neonatal Abstinence Syndrome? Am J Perinatol. 2022 07; 39(10):1138-1144.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement